Northern Capital Management (Wisconsin)’s Intra-Cellular Therapies Inc. ITCI Stock Holding History

Northern Capital Management (Wisconsin)’s Portfolio ITCI Stock Details ITCI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-14,120	Closed	-$215K	–	148
2016 Q3	$215K	Sell	14,120 -65	-0.5%	-$2.63K	0.1%	130
2016 Q2	$551K	Sell	14,185 -2,440	-15%	-$87.7K	0.25%	102
2016 Q1	$462K	Buy	+16,625	New	+$554K	0.21%	112
2015 Q3	–	Sell	-6,655	Closed	-$213K	–	163
2015 Q2	$213K	Buy	+6,655	New	+$169K	0.1%	129
2015 Q1	–	Sell	-12,175	Closed	-$215K	–	156
2014 Q4	$215K	Buy	+12,175	New	+$190K	0.11%	133

Other funds holding ITCI

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

TCM

TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

HIM

Hillhouse Investment Management Grand Cayman, Cayman Islands $3.13B AUM 7.29% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Capital Management (Wisconsin)'s ITCI Position: Q4 2016 in Review

Northern Capital Management (Wisconsin) sold out of Intra-Cellular Therapies Inc. (ITCI) in Q4 2016, closing a stake of 14,120 shares — an estimated $215K sold.

Northern Capital Management (Wisconsin) first reported a position in ITCI in Q4 2014 and held it in 5 quarters. The position peaked at $551K in Q2 2016. 129 funds tracked by Wall St. Rank hold ITCI as of Q4 2016.

Northern Capital Management (Wisconsin) reported no remaining Intra-Cellular Therapies Inc. position as of Q4 2016 after selling out during the quarter.
Northern Capital Management (Wisconsin) sold 14,120 Intra-Cellular Therapies Inc. shares in Q4 2016, an estimated $215K.
Northern Capital Management (Wisconsin) first reported a position in Intra-Cellular Therapies Inc. in Q4 2014 and held it in 5 quarters.
Northern Capital Management (Wisconsin)'s Intra-Cellular Therapies Inc. position peaked at $551K in Q2 2016.
129 funds tracked by Wall St. Rank held Intra-Cellular Therapies Inc. as of Q4 2016.

Based on Northern Capital Management (Wisconsin)'s 13F filing for Q4 2016, filed 27 Jan 2017.